116 related articles for article (PubMed ID: 7838041)
1. Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.
Mastrangelo R; Lasorella A; Riccardi R; Colosimo C; Iavarone A; Tornesello A; Mastrangelo S; Ausili-Cefaro G; Di Rocco C
Med Pediatr Oncol; 1995 Mar; 24(3):188-96. PubMed ID: 7838041
[TBL] [Abstract][Full Text] [Related]
2. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
[TBL] [Abstract][Full Text] [Related]
3. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
[TBL] [Abstract][Full Text] [Related]
4. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
Stewart CF; Iacono LC; Chintagumpala M; Kellie SJ; Ashley D; Zamboni WC; Kirstein MN; Fouladi M; Seele LG; Wallace D; Houghton PJ; Gajjar A
J Clin Oncol; 2004 Aug; 22(16):3357-65. PubMed ID: 15310781
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial and pharmacokinetics of carboplatin 560 mg/m2 in children.
Doz F; Brugières L; Bastian G; Quintana E; Lemerle J; Zucker JM
Med Pediatr Oncol; 1990; 18(6):459-65. PubMed ID: 2233516
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.
Cohen BH; Packer RJ
J Neurooncol; 1996 Jul; 29(1):55-68. PubMed ID: 8817416
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).
Gentet JC; Doz F; Bouffet E; Plantaz D; Roché H; Tron P; Kalifa C; Mazingue F; Sariban E; Chastagner P
Med Pediatr Oncol; 1994; 23(5):422-7. PubMed ID: 8084309
[TBL] [Abstract][Full Text] [Related]
12. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
15. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
[TBL] [Abstract][Full Text] [Related]
16. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma.
Di Rocco C; Iannelli A; La Marca F; Tornesello A; Mastrangelo S; Riccardi R
Childs Nerv Syst; 1995 Oct; 11(10):574-8. PubMed ID: 8556723
[TBL] [Abstract][Full Text] [Related]
18. [Safe and effective administration of carboplatin-based chemotherapy in a patient undergoing hemodialysis with cancer of unknown primary by monitoring observed AUC of carboplatin-a case report].
Kondo M; Kuroda J; Ikai Y; Hayashi R; Uegaki S; Yoshida T; Yoshida A; Komatsu H; Kimura K
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1749-52. PubMed ID: 23152033
[TBL] [Abstract][Full Text] [Related]
19. Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin.
Borsi JD; Csaki C; Ferencz T; Oster W
Anticancer Drugs; 1996 Jan; 7(1):121-6. PubMed ID: 8742109
[TBL] [Abstract][Full Text] [Related]
20. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
